Table of Contents
What changed
Revenue rose 21.9% to NZ$350.8m and profit before tax grew 27.8% to NZ$47.0m. NPAT grew a softer 20.0% to NZ$33.3m because income tax expense rose to NZ$13.6m and the effective tax rate lifted to 29.0% from 24.4%; there were no discontinued operations, so the PBT-to-NPAT gap is fully tax-driven. Gross margin compressed about 144bps to 57.4% as cost of sales grew faster than sales. Operating cash inflow fell 13.9% to NZ$61.4m despite higher earnings, and closing cash dropped NZ$10.4m to NZ$39.2m. On the segment mix, Glassons Australia grew to NZ$133.6m (38.1% of group revenue, up 4.5pp) and became the largest segment ahead of Glassons New Zealand at NZ$119.9m; Hallensteins grew more slowly to NZ$97.2m. Total liabilities fell 11.3% to NZ$110.3m while equity edged up 2.4% to NZ$89.2m.
What matters
- Cash conversion deteriorated materially. Operating cash flow fell NZ$9.9m even as PBT grew NZ$10.2m. With inventory up 12.9% to NZ$27.8m and capex cut to NZ$7.9m from NZ$11.8m (2.2% of revenue versus 4.1%), pre-lease free cash flow of NZ$53.5m still covered NPAT 1.6x, but the gap between reported earnings quality and cash generation has widened.
- Australia is now the growth engine. Glassons Australia revenue rose 38.2% and carries the highest disclosed current segment margin (~12.3%), while Hallensteins delivered a weaker ~5.0% margin on slower sales growth. The group's earnings trajectory is increasingly a read on Australian execution and, implicitly, on unhedged NZD/AUD translation.
- Final dividend deferred. The release explicitly defers declaration of the final dividend pending the Auckland and Australian trading outlook, a material capital-allocation signal even against a 27.8% PBT uplift.
Expectations
No quantitative forward-work or earnings targets were disclosed in the supplied excerpts. HY21 accounted for 51.9% of FY21 revenue but 59.6% of FY21 NPAT, implying a modestly first-half-weighted profit profile — consistent with a stronger second-half lockdown impact on trading, which also frames management's caution on the final dividend. Because there is no guidance or forward order book, the release does not support a confident FY22 shape and does not quantify the ongoing Auckland/Australia disruption risk it flags.
Quality of result
The PBT step-up looks operationally real: revenue grew 21.9% and operating profit grew 25.8% on a lower capex base, so scale leverage genuinely improved. However, several quality offsets sit alongside that. Gross margin compressed 144bps, so the earnings uplift came from volume and operating deleverage rather than price/mix strength. Working capital helped the P&L less than last year — inventory built NZ$3.2m and operating cash fell despite higher profit, so cash conversion weakened versus FY20's exceptionally strong NZ$71.3m. Capex at 2.2% of revenue is roughly half the prior year's intensity, which flatters free cash flow and may not be a sustainable run-rate. Net debt and gross borrowings were not disclosed, so the apparent balance-sheet improvement (liabilities down 11.3%) cannot be decomposed between lease reduction and interest-bearing debt repayment.
Unresolved
- What is the gross borrowings and net debt position, and how much of the NZ$14.0m liability reduction is interest-bearing versus lease-related?
- What drove the 144bps gross margin compression — freight, promotional intensity, or AUD translation — and is it recoverable?
- How much of the lower capex is deferral versus a structural shift, and what is the normalised capex intensity for the Australian store expansion?
- What is the FY22 trading picture into the Auckland and Australian lockdowns that prompted the dividend deferral, and when will the final dividend be declared?
- Is there any hedging disclosure or quantified FX sensitivity given Australia is now the largest segment?
This briefing cannot assess valuation, leverage ratios, or dividend coverage because net debt, gross borrowings, and the declared dividend per share were not disclosed in the supplied data.
Key metrics
| Metric | FY21 | FY20 | Change |
|---|---|---|---|
| Revenue | $350.8m | $287.8m | +21.9% ↑ |
| Net profit after tax | $33.3m | $27.8m | +20.0% ↑ |
| Net cash inflow from operating activities | $61.4m | $71.3m | -13.9% ↓ |
| Operating profit | $49.3m | $39.2m | +25.8% ↑ |
| Profit before tax | $47.0m | $36.7m | +27.8% ↑ |
| Cash and cash equivalents | $39.2m | $49.6m | -21.0% ↓ |
| Total assets | $199.5m | $211.4m | -5.7% ↓ |
Reference: annolyse.ai/briefings/hlg-fy21
Segment breakdown
| Segment | Current revenue | Prior revenue | Current result | Mix shift |
|---|---|---|---|---|
| Glassons New Zealand | $119.9m | $102.6m | $11.6m | -1.5pp |
| Glassons Australia | $133.6m | $96.7m | $16.4m | +4.5pp |
| Hallensteins | $97.2m | $88.5m | $4.8m | -3.0pp |
| Property | $0m | $0m | $0.5m | +0.0pp |
Reference: annolyse.ai/briefings/hlg-fy21
Analytical metrics
| Metric | FY21 | FY20 | Context |
|---|---|---|---|
| PBT growth | +27.8% | — | cleaner earnings measure |
| Effective tax rate | 29.0% | 24.4% | — |
| FCF pre-lease | $53.5m | $59.5m | −$5.9m |
| FCF / NPAT | 160.7% | 214.2% | complementary conversion metric |
| Capex % revenue | 2.2% | 4.1% | — |
| Capex | $7.9m | $11.8m | −$3.9m |
| Debtor days | 0.2 | 3.0 | -2.7 days |
| Inventory days | 28.9 | 31.2 | -2.3 days |
| Trade debtors | $0.2m | $2.3m | −$2.1m |
| HY21 share of FY21 revenue | 51.9% | — | Other half was 48.1% |
| HY21 share of FY21 NPAT | 59.6% | — | Other half was 40.4% |
| Profit from continuing operations | $33.3m | $27.8m | +$5.5m |
Reference: annolyse.ai/briefings/hlg-fy21
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX/ASX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.